{"id":831,"date":"2013-01-01T12:01:00","date_gmt":"2013-01-01T11:01:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2013\/verordnungen-und-preise-einiger-im-amb-besprochenen-arzneimittel-basierend-auf-dem-arzneiverordnungs-report-2012-datenbasis-des-jahres-2011-gkv-arzneimittelindex-im-wido-preisstand-1-januar-2013"},"modified":"2022-03-17T14:12:34","modified_gmt":"2022-03-17T13:12:34","slug":"verordnungen-und-preise-einiger-im-amb-besprochenen-arzneimittel-basierend-auf-dem-arzneiverordnungs-report-2012-datenbasis-des-jahres-2011-gkv-arzneimittelindex-im-wido-preisstand-1-januar-2013","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2013\/verordnungen-und-preise-einiger-im-amb-besprochenen-arzneimittel-basierend-auf-dem-arzneiverordnungs-report-2012-datenbasis-des-jahres-2011-gkv-arzneimittelindex-im-wido-preisstand-1-januar-2013","title":{"rendered":"Verordnungen und Preise einiger im AMB besprochenen Arzneimittel, basierend auf dem Arzneiverordnungs-Report 2012, Datenbasis des Jahres 2011: GKV-Arzneimittelindex im WIdO. Preisstand 1. Januar 2013."},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[909,2192,1149,405,2193,905,897,1351,2191],"class_list":["post-831","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-aripiprazol","tag-botulinumtoxin","tag-neuroleptika","tag-olanzapin","tag-onabotulinumtoxin-a","tag-quetiapin","tag-risperidon","tag-solifenacin","tag-trospiumchlorid"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=831"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/831\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}